Loading Events

Go Back

event image

POSTPONED – Regional Summit Series on B-cell and Plasma Cell Malignancies – New York, NY

April 4, 2020

OVERVIEW

Update: This meeting has been postponed due to COVID-19 spread. Please send any inquiries to omi@davaonc.com and check back soon for new dates. 

Oncology Meeting Innovations’ (OMI’s) Regional Summit on B-Cell and Plasma Cell Malignancies is a one-day meeting that engages local community oncologists to discuss the current treatment options in CLL, Lymphoma, and Multiple Myeloma. Topics will include recently approved drugs and agents in late-stage development, best practices for employing approved compounds in B-Cell and Plasma Cell Malignancies, and relevant case presentations. This meeting will assemble a distinguished group of key opinion leaders to present leading strategies for employing latest advances, managing risk, and prolonging patient survival. Additionally, the audience will have the opportunity to engage the experts with questions and case-study discussion.

Event brochure is available here

KEY TOPICS

  • Discuss how to assess risk in CLL
  • Review recent advances and new data for treating CLL, lymphoma, and multiple myeloma
  • Examine advances in targeting BTK, PI3K, and BCL-2 inhibition
  • Discuss how to treat indolent lymphoma
  • Identify novel therapies for use in CLL, lymphoma and multiple myeloma

PROGRAM CHAIRS

POSTPONED – Regional Summit Series on B-cell and Plasma Cell Malignancies – New York, NY

Andrew Zelenetz, MD, PhD

Medical Director, Quality Informatics
Memorial Sloan Kettering Cancer Center
New York, NY